"The two sides acknowledged that discussions are underway to initiate programmes on vaccines for TB, dengue, and respiratory syncytial virus (RSV) with public-private partnerships mode under the US-India Vaccine Action Program," a joint statement on the second India-US Strategic and Commercial Dialogue said.
The statement comes a day after US Secretary of State John Kerry, who is on a visit to India, said that in order to halt unnecessary loss of lives and to prevent diseases, the US intends to develop and start clinical trials for vaccines against dengue and tuberculosis.
Both India and the US also reaffirmed their commitment to the detection and treatment of tuberculosis, another major public health challenge, especially in urban areas which are combating multi-drug resistant TB with the support of USAID.
Both the nations decided to continue their work under the Indo-US pact for cooperation on cancer research, its prevention, control as well as management.
Also Read
The two sides expressed happiness over the initiation of the second round of the Global Adult Tobacco Survey (GATS) in India in technical partnership with the US CDC and decided to reconvene the next round of India-US Health Dialogue this year.
Both sides welcomed the progress toward an MOU between the Department of Health and Human Services (HHS) and Ministry of AYUSH, noting their broad and expanding collaboration on infectious diseases and the Global Health Security Agenda (GHSA).
"They welcomed the establishment of the GHSA cell within the Ministry of Health and Family Welfare," the statement said. Both the countries also discussed the expansion of the India Epidemic Intelligence Service (IEIS) - a post-graduate field training programme initiated in 2012 with CDC technical assistance.
Disclaimer: No Business Standard Journalist was involved in creation of this content